OraSure Technologies (OSUR) Proxy filing summary

Executive summary

• Announced appointment of John D. Bertrand as independent director, bringing AI-enabled diagnostics expertise to the board.

• Entered into a Cooperation Agreement with Altai Capital, resulting in Altai withdrawing its director nominations and establishing regular meetings on financial and strategic matters.

• Forward-looking statements caution that actual results may differ due to various known and unknown factors, with further details available in SEC filings.

Voting matters and shareholder proposals

• Board will seek shareholder approval to declassify itself at the 2026 Annual Meeting, with details to be included in the upcoming proxy statement.

Board of directors and corporate governance

• John D. Bertrand appointed to the board, enhancing expertise in healthcare technology and AI.

• Board declassification proposal reflects commitment to strong governance and shareholder engagement.

• Cooperation Agreement with Altai Capital includes standstill and voting provisions, to be filed with the SEC.